Save my name, email, and website in this browser for the next time I comment. Sign in. Log into your account. Password recovery. Monday, February 22, Forgot your password?
Calls for women to participate in breast cancer screening
Breast Cancer Screening Guidelines | American Cancer Society
An estimated 23, women are projected to be diagnosed with breast cancer and 5, women to die from the disease in Early detection of breast cancer, through organized mammography screening programs, is an effective method to reduce death and morbidity associated with breast cancer. This is partially because primary prevention of breast cancer has been limited: most known risk factors are not easily modifiable. Of known risk factors, age has the strongest influence on breast cancer incidence; roughly, half of all new cases are among women between 50 and 69 years of age. Modelling exercises have shown that the delivery of high quality breast screening programs to this age group has the potential to reduce breast cancer deaths by as much as one third. Many provinces and territories also provide screening services to other age groups but in a less targeted fashion.
Breast Cancer Screening Guidelines
Screening and Early Detection Home. Breast Cancer Ductal Carcinoma in Situ.
The American Cancer Society recommends that women undergo regular screening mammography for the early detection of breast cancer. Review a consumer-friendly version of the American Cancer Society's screening guidelines for breast cancer, as well as information on risk factors and methods of reducing risk. View supplementary materials accompanying the MRI screening recommendations describing several models that can estimate risk based on complex family histories and assist clinicians in estimating breast cancer risk or the likelihood that a BRCA mutation is present. Full text: ACS recommendations and rationale for breast cancer screening Summary of the systematic evidence review on benefits and harms of breast cancer screening Complete systematic evidence review used in updating the ACS breast cancer screening guideline Duke Evidence Synthesis Group.